b'20BIOGRAPHIESLee Ellington, PhD,is a Professor at the College of Nursing University of Utah anda clinical psychologist, and she holds the Robert S. and Beth M. Carter Endowed Chair.Her program of research focuses on the impact of interpersonal health communicationon health and wellbeing. For the last decade her team has focused their communication research on hospice care of families facing cancer. Additionally, she co-directs the T32, Interdisciplinary Training in Cancer, Caregiving, and End-of-Life Care. Dr. Ellington is founder and Director of the Family Caregiving [email protected] Enzinger, MD,is an Assistant Professor of Medicine at Harvard Medical School, and a board-certified Medical Oncologist and Palliative Medicine Physician at Dana-Farber Cancer Institute. She is mentor to Dr. Desiree Azizoddin, 2020 NPCRC Kornfeld Scholar. Her research focuses on novel care delivery approaches to improving cancer pain management and improving communication around prognosis and treatment planningin the advanced cancer [email protected] Feraco, MD, MMSc,is an Assistant Professor of Pediatrics at Harvard Medical School and a pediatric oncologist at Dana-Farber/Boston Childrens Cancer and Blood Disorders Center. Dr. Feraco studies interprofessional collaboration and communication among pediatric oncology teams and pediatric palliative care teams. Ultimately, Dr. Feraco seeks to leverage meaningful teamwork and high-quality communication to enhance quality of life for children with cancer at every phase of the illness. She is a past Chair of the Palliative Care Special Interest Group for the American Society of Pediatric Hematology/Oncology. Dr. Feraco is a 2017 NPCRC Jr. Faculty Career Development Award grantee and a 2020 Cambia Foundation Sojourns [email protected] Fischer, MD,is an Associate Professor in the Division of General Internal Medicine at the University of Colorado School of Medicine and Program Leader at the Cancer Center. Her research has centered on improving palliative care-focused outcomes for underserved populations using innovative approaches to address work force shortages. Her current research involves testing psilocybin-assisted psychotherapy for persons with advanced cancer to improve anxiety, depression, and existential distress through NCI funding.Dr. Fischer is a 2017 NPCRC grantee. [email protected]'